$338M
$9.11 Million
0.0% of portfolio
9,111,069
Q3 2024
Added 0.26%
$59.2B
$224,000
0.0% of portfolio
3,664
Q3 2024
New
$75.4B
$36.4 Million
0.0% of portfolio
310,572
Q3 2024
Reduced 5.28%
Canadian Pacific Kansas City
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 5.23%
$765M
$8.16 Million
0.0% of portfolio
486,800
Q3 2024
Added 5.62%
$132M
$3.41 Million
0.0% of portfolio
492,005
Q3 2024
Added 4.06%
$1.69B
$30.6 Million
0.0% of portfolio
1,605,351
Q3 2024
Added 1.61%
-
$0
0.0% of portfolio
-
Q3 2024
Added 2.83%
$660M
$9.16 Million
0.0% of portfolio
1,237,888
Q3 2024
Added 2.44%
$401M
$4.52 Million
0.0% of portfolio
175,639
Q3 2024
Added 0.88%
$664M
$12 Million
0.0% of portfolio
341,426
Q3 2024
Added 1.78%
$957M
$34.9 Million
0.0% of portfolio
5,976,852
Q3 2024
Reduced 4.73%
$440M
$7.79 Million
0.0% of portfolio
512,313
Q3 2024
Added 27.75%
$16.7M
$55,000
0.0% of portfolio
180,400
Q3 2024
Reduced 0.22%
$109M
$2.22 Million
0.0% of portfolio
832,652
Q3 2024
Added 3.43%
-
$0
0.0% of portfolio
-
Q1 2024
Added 116.42%
$129M
$2.79 Million
0.0% of portfolio
873,332
Q3 2024
Reduced 1.97%
$45.8M
$136,000
0.0% of portfolio
44,763
Q3 2024
Reduced 6.87%
$1.24B
$63.6 Million
0.0% of portfolio
2,036,089
Q3 2024
Reduced 3.4%
-
$0
0.0% of portfolio
-
Q3 2024
Added 11.7%
$3.66B
$99.1 Million
0.0% of portfolio
3,298,894
Q3 2024
Added 4.83%
$123M
$3.16 Million
0.0% of portfolio
1,618,243
Q3 2024
Added 0.16%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 83.79%
$61M
$189,000
0.0% of portfolio
210,138
Q2 2024
Reduced 79.06%
$576M
$9.45 Million
0.0% of portfolio
287,960
Q3 2024
Added 0.21%
$1.31B
$40.5 Million
0.0% of portfolio
2,419,422
Q3 2024
Added 0.63%
$450M
$8.64 Million
0.0% of portfolio
496,603
Q3 2024
Added 4.14%
$2.06B
$72.5 Million
0.0% of portfolio
1,115,330
Q3 2024
Reduced 0.43%
Cartesian Therapeutics Inc
-
$0
0.0% of portfolio
-
Q3 2024
Added 2.49%
$614M
$13.2 Million
0.0% of portfolio
319,177
Q3 2024
Added 0.78%
$1.06B
$34.2 Million
0.0% of portfolio
1,162,749
Q3 2024
Reduced 1.21%
$6.64M
$8,000
0.0% of portfolio
49,900
Q3 2023
Added 230.46%
$784M
$19.4 Million
0.0% of portfolio
680,001
Q3 2024
Added 9.84%
$2.21B
$113 Million
0.0% of portfolio
5,685,330
Q3 2024
Reduced 5.77%
$70.5M
$330,000
0.0% of portfolio
66,246
Q2 2024
Reduced 83.76%
-
$0
0.0% of portfolio
-
Q3 2024
Added 33.29%
$153M
$319,000
0.0% of portfolio
11,441
Q4 2022
Reduced 1.72%
$78.3M
$326,000
0.0% of portfolio
261,170
Q3 2024
Reduced 1.96%
$4.15B
$76.1 Million
0.0% of portfolio
1,130,848
Q3 2024
Added 0.94%
$948M
$14.8 Million
0.0% of portfolio
585,559
Q3 2024
Reduced 0.32%
$7.73B
$82.2 Million
0.0% of portfolio
7,446,518
Q3 2024
Added 32.25%
$0
$0
0.0% of portfolio
659,315
Q3 2024
Added 0.13%
$26M
$205,000
0.0% of portfolio
193,507
Q2 2024
Reduced 0.26%
$197M
$16.5 Million
0.0% of portfolio
1,107,415
Q3 2024
Added 152.2%
-
$0
0.0% of portfolio
-
Q3 2024
New
$1.26B
$84.4 Million
0.0% of portfolio
2,485,156
Q3 2024
Reduced 6.54%
$3.74B
$7.47 Million
0.0% of portfolio
443,700
Q3 2024
Added 7.27%
Cellectar Biosciences Inc
-
$0
0.0% of portfolio
-
Q2 2024
Added 10.81%
-
$0
0.0% of portfolio
-
Q2 2024
Added 6.82%
$7.97B
$10.4 Million
0.0% of portfolio
1,709,843
Q3 2024
Reduced 3.96%